Dentists are at high risk of SARS-CoV-2 infection due to their close proximity to patients. Thus, the fear of contamination or spreading the virus to family members, coupled with financial need, can lead professionals to experience significant overload and psychological suffering. We investigated the perceptions of dental professionals in the public and private sectors regarding fear and anxiety related to patient care and the risk of infection in the face of the COVID-19 pandemic. Based on the previous literature, we interviewed 302 dentists online using sociodemographic and professional questions. Among the professionals evaluated, 80.8% had suspended their activities for some time, 74.8% were afraid of infection at work, 86.1% feared transmitting the virus to their families, 30.1% had already been infected, 54% felt afraid when they heard the news of death caused by SARS-CoV-2, and 63.9% reported having the protective knowledge necessary to avoid infection. Dentists who worked only in the public sector and those who worked in both sectors were more afraid of being infected than professionals who worked only in private offices. Our results highlight the impact of the COVID-19 pandemic on emotional health in dentists. This study highlights the need for more support in the psychosocial field to enable dentists to overcome difficulties and maintain the provision of good dental care for the population. Continuing education should update professions with the requisite scientific and clinical knowledge to face the pandemic and achieve greater reflection on their role within this new context to improve their professional and emotional performance.
This meta-analysis aimed to investigate the effects of propolis on the severity of coronavirus disease symptoms by reducing periodontal disease. PubMed, EMBASE, SciELO, Web of Science, and SCOPUS databases were systematically searched. Studies have been conducted analyzing propolis's effects on COVID-19 and periodontitis. The study was conducted according to the PRISMA statement and registered in PROSPERO. Risk of Bias (RoB) assessment and meta-analysis of clinical studies were performed (Review Manager 5, Cochrane). The certainty of the evidence was assessed using GradePro (GDT). Studies have shown propolis flavonoids inhibit viral replication in several DNA and RNA viruses, including coronaviruses. Propolis components have an aminopeptidase inhibitor activity that can inhibit the main proteases of SARS viruses and seem to inhibit protein spikes, which are sites of most mutations in SARS-CoV strains. The meta-analysis showed favorable results with the use of propolis on probing depth (95%CI: 0.92; p < 0.001), clinical attachment level (95%CI: 1.48; p < 0.001), gingival index (95%CI: 0.14; p = 0.03), plaque index (95%CI: 0.11; p = 0.23), and blending on probing (95%CI: 0.39; p < 0.001). The antibacterial activity of propolis could be mediated through its direct action on microorganisms or the stimulation of the immune system, activating natural defenses. Thus, propolis inhibits the replication of SARS-CoV-2 as well as its bacterial activity. Treatment with propolis improves general health and facilitates the activation of the immune system against coronavirus.
This systematic review aimed to investigate the COVID-19 biological risk based in knowledge, attitudes and perception of dentists during COVID-19 pandemic and to establish a clinical protocol based on the literature. The protocol was conducted in accordance to PRISMA Statement and registered on International Prospective Register of Systematic Reviews (CRD42020200258). PubMed, Embase and SciELO were systematically searched, using the key terms "coronavirus infections" AND "dentists". Four articles were selected for qualitative and ten for quantitative analysis. The overall studies reported characteristics of dentists (n = 12,913) who completed survey questionnaires: male (n = 6,690; 51.8%); knowledge: transmission route (n = 1,892; 14.65%), use of personal protective equipment (PPE) (n = 2,418; 18.7%) and signs and symptoms (n = 1,489; 11.5%); attitudes: urgency treatment (n = 2,633; 20.4%), handwashing (n = 5,548; 43%), reducing patients in waiting room (n = 3,020; 23.4%), and use of masks (n = 4,068; 31.5%); and perception: infection risk (n = 2,387; 18.5%). The clinical protocol includes procedures before appointments, correct handling of the operative area, and use of correct PPE. The primary COVID-19 biological risks are infectivity and horizontal transmission. The clinical care protocol in dentistry should be adopted by all dentists to reduce biological risk. Thus, dentists may play an important role in the prevention and interruption of SARS-CoV-2 transmission chain.
Odontologia e Integralidade do Cuidado: aspectos da formação profissional e dos serviços de saúde 102 Palavras-chave: COVID-19, Biossegurança, Odontologia. RESUMOÉ fundamental aprimorar as estratégias de prevenção e proteção ao coronavirus (SARS-CoV-2) para profissionais de saúde, especialmente para os cirurgiões-dentistas, que estão altamente expostos à contaminação. A COVID-19 é uma doença que causa infecções respiratórias, que podem causar vários distúrbios sistêmicos importantes. O indivíduo contaminado pode apresentar desde sintomas mais leves até outros mais graves, que podem progredir para pneumonia e em alguns casos para o óbito. A alta transmissibilidade e a natureza pandêmica da doença amplificam a importância da formulação de um consenso dentro da comunidade odontológica, para combater essa ameaça emergente. O conhecimento das características inerentes do patógeno, assim como as respectivas medidas para prevenção são de suma importância, para o atendimento clínico no período de pandemia. O serviço odontológico é essencial para a manutenção da saúde bucal, influenciando desta forma, a saúde sistêmica dos pacientes. Medidas de biossegurança devem ser seguidas criteriosamente pelo cirurgião dentista, a fim de garantir a diminuição da disseminação do SARS-CoV-2 e a quebra da cadeia de transmissão, para ambientes dentro e fora do consultório odontológico.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.